Literature DB >> 21159834

The functional polymorphism 844 A>G in FcαRI (CD89) does not contribute to systemic sclerosis or rheumatoid arthritis susceptibility.

Jasper C A Broen1, Marieke J H Coenen, Blanca Rueda, Torsten Witte, Leonid Padyukov, Lars Klareskog, Roger Hesselstrand, Dirk M Wuttge, Carmen Simeon, Norberto Ortego-Centeno, Miguel A González-Gay, Anna Pros, Nicholas Hunzelman, Gabriela Riemekasten, Alexander Kreuter, Madelon Vonk, Rafaella Scorza, Lorenzo Beretta, Paulo Airò, Piet L C M van Riel, Robert Kimberly, Javier Martin, Jeffrey Edberg, Timothy R D J Radstake.   

Abstract

OBJECTIVE: To investigate the role of the Fc(α)RI 844 A>G functional polymorphism in the genetic predisposition to rheumatoid arthritis (RA) and systemic sclerosis (SSc) susceptibility.
METHODS: The study population was composed of 1401 patients with SSc, 642 patients with RA, and 1317 healthy controls. The Fc(α)RI (CD89) single-nucleotide polymorphism rs16986050 was genotyped by pyrosequencing.
RESULTS: We observed no significant deviation of the genotype and allele frequencies in RA and SSc compared to controls. A metaanalysis and a recessive and dominant model yielded similar negative results.
CONCLUSION: Our data show that the Fc(α)RI 844 A>G polymorphism is not associated with SSc or RA susceptibility.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21159834     DOI: 10.3899/jrheum.100427

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  2 in total

Review 1.  Genetics of systemic sclerosis: an update.

Authors:  Jasper C A Broen; Marieke J H Coenen; Timothy R D J Radstake
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

Review 2.  Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools.

Authors:  Sanae Ben Mkaddem; Marc Benhamou; Renato C Monteiro
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.